Three patients with spinal primary diffuse-type tenosynovial giant cell tumor (DTGCT) received surgical treatment in our department between 2002 and 2012. All 3 patients were female and aged 23, 33, and 44 years. The mean time from symptom onset to diagnosis was 17 months (range, 5-24 months). One case involved the C1 right lateral mass and C2 vertebral body, the second involved the C1-2 left lateral masses and C2 vertebral body, and the third involved the C5-7 left lateral mass and C6 vertebral body. All patients underwent computed tomographyguided biopsy to confirm the diagnosis of tenosynovial giant cell tumor. Gross total resection was achieved in all patients, including 2 piecemeal resections and 1 en-bloc resection. The mean follow-up time was 6 years (range, 1-11 years), and there was no sign of recurrence in the patients. Seventy cases have been identified so far in the English literature. The male to female ratio is 1:1.38. The mean patient age is 38.5 ± 17.9 years. The tumor distribution includes 32 cases in the cervical spine, 14 in the thoracic spine, 22 in the lumbar spine, and 1 in the sacrococcygeal region. The recurrence rate for patients who underwent gross total resection was 7.7%, and tumor progression was observed in 66.7% of patients who underwent subtotal resection. Above all, DTGCT is a rare primary spinal neoplasm. Preoperative image-guided biopsies play an important role in the diagnosis and treatment strategy. Gross total resection is the best treatment strategy and can reduce the recurrence rate. (aralık, 5-24 ay). Bir olguda C1 sağ lateral kitle ve C2 vertebral cisim tutulması vardı. İkinci olguda C1-2 sol lateral kitleleri ve C2 vertebra cismi tutulmuştu. Üçüncü olguda C5-7 sol lateral kitleleri ve C6 vertebra cismi tutulmuştu. Tüm hastalarda tenosinov yal dev hücreli tümör tanısını doğrulamak için bilgisayarlı tomografi kılavuzluğunda biyopsi yapıldı. Tüm hastalarda gros total rezeksiyon yapıldı. Hastaların ikisinde parça parça ve 1'inde ise en blok halinde rezeksiyon ile gerçekleştirildi. Ortalama takip süresi 6 yıldı (aralık, 1-11 yıl) ve hastalarda bir nüks bulgusu yoktu. İngilizce literatür-de şimdiye kadar 70 olgu tanımlanmıştır. Erkek/kadın oranı 1:1,38'dir. Ortalama hasta yaşı 38,5 ± 17,9 yıldır. Tümör dağılımı servikal omurgada 32 olgu, torasik omurgada 14 olgu, lomber omurgada 22 olgu ve sakrokoksigiyal bölgede 1 olgu şeklindedir. Gros total rezeksiyon yapılan hastalarda nüks oranı %7,7 bulunmuş ve subtotal rezeksiyon yapılan hastaların %66,7'sinde tümör ilerlemesi gözlenmiştir. Genel olarak DTGCT nadir bir primer spinal neoplazmdır. Preoperatif tomografi kılavuzluğunda biyopsiler, tanı ve tedavi stratejisinde önemli bir rol oynamaktadır. En iyi tedavi gros total rezeksiyondur.
INTRODUCTION
Diffuse-type tenosynovial giant cell tumors (DTGCT) are a type of aggressive benign tumor thought to originate from tendon sheaths, bursae, or diarthrodial joint synovium (5) . The etiology of DTGCT remains unknown, and DTGCT was previously named extra-articular PVNS because it shares similar histological characteristics with pigmented villonodular synovitis (PVNS) (39) . DTGCT occurs mainly in middle-aged women and usually involves large loadbearing joints such as the knee, ankle, and hip, whereas clinical case reports of DTGCT involving the spine are rare. We retrospectively analyzed a case series of 3 patients diagnosed with spinal DTGCT. The common characteristics, imaging and pathological manifestations, diagnosis and
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treatment strategies, and follow-up data from these cases were retrospectively reviewed. Additionally, case reports in the English literature were systematically reviewed.
CASE REPORTS

Case 1
Patient 1 was a 23-year-old woman who experienced neck pain and discomfort over a 2-year period. No limitations in the cervical range of motion (ROM) were noted. The neurological examination was completely normal.
Imaging:
The computed tomography (CT) examination revealed a 6×4×6 cm osteolytic lesion on the C1 right lateral mass and the C2 vertebral body ( Figure 1A ). Magnetic resonance imaging (MRI) demonstrated a lobulated mass that originated in the C1 right lateral mass, with significant paravertebral expansion. Heterogeneous isointensity was identified on the T1-weighted images, and high-signal intensity was identified on the T2-weighted images ( Figure  1B ).
Treatment:
A single-stage combined anterior and posterior piecemeal total resection was performed, and stability reconstruction was achieved via a combination of anterior and posterior internal fixation (nail-plate system and occipitocervical fusion with iliac graft). The intraoperative blood loss was 1500 mL, and the surgery duration was 420 min. After 2.5 years, the posterior internal fixation was removed because of unbearable axial neck pain. The postoperative pathological examination confirmed the diagnosis of DTGCT.
Follow-up examination:
The follow-up time was 11 years. The CT images taken at the last follow-up examination showed achievement of solid bone fusion and no sign of recurrence ( Figure 1C ).
Case 2
The second patient was a 33-year-old woman who experienced neck pain and right hand numbness over a 2-year period. The neurological examination indicated a medial-side sensory loss in the forearm and ring finger.
Imaging: CT images showed a giant osteolytic and expansive bone-destructive lesion centered in the C6 left lateral mass and lamina; the C5 and C7 lateral masses were also involved, and the cortical bone was eroded (Figure 2A ). MRI revealed a lobulated mass, with significant expansion to the spinal canal and paravertebral areas. High-signal intensity was identified on the T1-weighted images, and low-signal intensity with patchy high-signal intensity was identified on the T2-weighted images ( Figure 2B ).
Treatment: A single-stage combined anterior and posterior piecemeal total resection was performed. The C6 vertebral body and lamina and the C5-7 left lateral masses were resected. Stability reconstruction was achieved via a combination of anterior and posterior internal fixation (nail-plate fixation from C3-T2 in the posterior approach and a titanium mesh fusion with iliac bone; Figure 2C ). The intraoperative blood loss was 800 mL, and the surgery duration was 300 min.
Follow-up:
The follow-up time was 6 years. The patient's right hand and forearm numbness significantly improved. The CT images at last follow-up examination showed no sign of recurrence ( Figure 2D ).
Case 3
The third patient was a 44-year-old woman who experienced neck pain and discomfort over a 2-year period. Her cervical range of motion (ROM) was significantly limited. The neurological examination was normal.
Imaging: Preoperative CT images showed an osteolytic lesion located at the odontoid, the C2 left vertebral body, and the C1-2 left lateral mass, whereas marginal sclerosis was visible ( Figure 3A ). MRI revealed a lobulated mass with high-signal intensity on the T1-weighted images and low-signal intensity on the T2-weighted images. Obvious enhancement was observed on the gadolinium diethylenetriamine penta-acetic acid (Gd-DTPA)-enhanced (administered intravenously) T1-weighted images ( Figure 3B ).
Treatment:
A single-stage combined anterior and posterior en-bloc resection was performed. The tumor capsule was intact. Stability reconstruction was achieved via a posterior Our systemic review mainly focused on the treatment strategies and prognosis for spinal PVNS/DTGCT. Among the 70 reported cases, imaging data from follow-up examinations performed beyond 1 year were available in 35 cases. Twenty-six patients (26/35, 74.3%) underwent gross total resection (GTR) of the tumors (24 underwent GTR, 1 underwent GTR combined with radiation therapy, and 1 underwent GTR combined with chemotherapy and radiation therapy). No tumor recurrence was observed at the last follow-up examination in 24 cases (24/26, 92.3%), and recurrence was observed in 2 cases (cases 16 and 18; 2/26, 7.7%). Nine patients (9/37, 24.3%) underwent subtotal resection of the tumor, and tumor progression was observed in 6 cases (6/9, 66.7%; includes 2 cases of malignant transformation and metastasis).
DISCUSSION
Tenosynovial giant cell tumors (TGCT) are aggressive soft tissue tumors that belong to a group of lesions that originate from the bursa or the tendon sheath synovium (30) . These lesions are classified into 3 types based on their location and encapsulation: nodular tenosynovitis, a localized extraarticular type; PVNS, a diffuse, non-encapsulated intraarticular type; and GCTTS or TGCT, a diffuse, extra-articular growth type. These various tumor types share similar histological findings. TGCT can further be classified as focaltype (FTGCT) or diffuse-type (DTGCT). FTGCT primarily occurs in the fingers and displays clear boundaries, whereas DTGCT occurs in large load-bearing joints such as the knee, hip, ankle, shoulder and elbow and lacks clear boundaries or displays capsular invasion (45); however, DTGCT, PVNS, and GCTTS were intermixed in the literature.
internal fixation (screw-rod system, occipitocervical fusion with iliac graft). The intraoperative blood loss was 1500 mL, and the surgery duration was 447 min.
Follow-up examination:
No recurrence was noted at the 1-year follow-up examination.
Pathological Analysis
Pathologically, all 3 patients were diagnosed with DTGCT, with the following features that differentiated these tumors from other lesions, especially giant cell tumors of the bone. The tumors were non-circumscribed with infiltrative growth into the surrounding tissues. The clefts appeared as synoviallike and pseudoalveolar spaces, and villous patterns could be detected. Mononuclear histiocyte-like cells with vesicular nuclei were the predominant cell type present. Some of the mononuclear cells contained cytoplasmic hemosiderin. Small numbers of osteoclastic giant cells were irregularly distributed throughout the lesions and were more frequently observed around hemorrhagic foci. Sheets of foam cells and scattered lymphocytes were also detected. No necrosis or other obvious features indicative of malignancy were present in the lesions ( Figure 4A,B) . The immunohistochemical analysis of the 3 patients is listed in Table I .
Systemic review of case reports in the English literature
Search strategy: Two reviewers independently searched the Ovid MEDLINE (1950-present), EMBASE (1980-present), and bibliographies for case reports of DTGCT/PVNS involving the spine. The searches were restricted to English language reports.
The following search terms were used: "diffuse-type tenosynovial giant cell tumor, " "DTGCT, " "pigmented villonodular synovitis, " "PVNS, " "giant cell tumor of tendon sheath, " "GCTTS, " "spinal neoplasms, " "spine, " and "spine tumor. " Any disagreement between the reviewers was resolved by a discussion with the other reviewer. Cases were included if they met the following criteria: a pathological diagnosis of PVNS or DTGCT (giant cell tumor of tendon sheath; GCTTS) and tumors involving the axial skeleton (from atlas to coccyx).
Data extraction:
The following information was collected from each case, using a standardized form: author and publication year, tumor location, sex and age, pathological diagnosis, treatment strategy, and follow-up data.
Searching results: After independently reviewing the titles and abstracts identified in the initial search according to the inclusion criteria, 87 cases were included in the full-text screening. Twelve repeatedly reported cases (13, 28), 2 cases of uncertain PVNS diagnoses (43) , and 3 non-English reports (19, 34, 37) were excluded. A total of 70 cases were included in the meta-analysis (Table II) 
Meta-Analysis
There were 29 men and 40 women (the gender was unavailable in 1 case) (46) , and the male to female ratio was 1:1.38. The 
DTGCT or PVNS involving the spine is extremely rare, and no rigorous reviews were reported in the literature. We report herein 3 cases of spinal DTGCT at our institute and have performed a systematic review of the literature based on the current best evidence. Some scholars believe that primary spinal DTGCT originates from facet joint synovial tissue and mainly grows extra-articularly rather than in the interior of the joint space (11), mostly in the cervical and lumbar vertebrae and rarely in the thoracic spine (13, 15) . Our study confirmed these beliefs, as women were more vulnerable to this type of tumor, 71.4% of spinal DTGCT/PVNS cases were reported to originate from facet joints, and 65.7% of these tumors expanded into the spinal canal. Overall, 77.1% of these tumors involved the cervical and lumbar spine.
DTGCT has no specific clinical and radiological manifestations; approximately 50% of patients have focal soft tissue mass shadows, which are occasionally accompanied by manifestations such as bone destruction, periosteal reactions, and calcification within the lesion (21, 28) . CT can identify pathological changes of the facet joint, bone destruction, and eroded adjacent vertebral bodies. MRI often shows equal or higher signals than muscle on T1-weighted images, whereas the features on T2-weighted images vary and can be characterized by hypointense, isointense, or hyperintense signals. The lack of specific MRI features can lead to confusion when distinguishing between giant cell tumors of the bone and aneurysmal bone cysts (24) .
Pathological manifestations provide the main diagnostic evidence. Histologically, DTGCT is characterized by the presence of monocytes and varying amounts of multinucleated giant cells, foam cells, chronic inflammatory cells, and hemosiderin (13) . In the present study, all patients underwent preoperative CT-guided biopsies, followed by histological and immunohistochemical analyses. For all 3 cases, the DTGCT diagnoses were preoperatively confirmed. Immunohistochemically, the biopsy specimens from all 3 cases were positive for vimentin and CD68, suggesting that monocytes comprised the majority of reactive cells in these DTGCT. These findings were consistent with the pathological characteristics of TGCT. Therefore, preoperative CT-guided biopsy is an important method for preoperative diagnoses and treatment strategy decisionmaking.
GTR was the best treatment strategy, according to our systematic review. The recurrence rate of patients who underwent GTR was only 7.7%, and tumor progression was observed in 66.7% of patients who underwent subtotal resection. Additionally, 2 cases of malignant transformation were observed in patients who underwent subtotal resection. In the present study, all 3 patients received extra-capsular total resections, and no tumor recurrence was observed during the long-term follow-up period. Recently, the intraoperative application of 300-mCi radiotherapy-assisted surgery has been shown to significantly reduce the postoperative recurrence rate of DTGCT of the knee joint (5). Furthermore, some scholars attempted to treat TGCT in the articulations of the appendicular skeleton with imatinib-targeted therapy (2). However, no such treatments were reportedly applied to spinal DTGCT.
CONCLUSION
In summary, primary spinal DTGCT is rarely reported. Diagnosis mainly depends on histological and immunohistochemical analyses. CT-guided biopsy is an important diagnostic method. GTR is the best treatment strategy and can reduce the recurrence rate. 
